SEOM clinical guideline on unknown primary cancer (2017)
- PMID: 29230692
- PMCID: PMC5785607
- DOI: 10.1007/s12094-017-1807-y
SEOM clinical guideline on unknown primary cancer (2017)
Abstract
Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, neuroendocrine carcinoma, and poorly differentiated carcinoma. Appropriate patient management requires understanding several clinical and pathological features that aid in identifying several subsets of patients with more responsive tumors.
Keywords: Cancer; Chemotherapy; Diagnosis and treatment; Unknown primary site.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Greco FA, Hainsworth JD. Cancer of unknown primary site. In: deVita VT, Jr Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 8. Philadelphia: Lippincott Williams and Wilkins; 2011. p. 2033.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
